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Abstract
Background: The term “intolerance” is not mentioned in the World Allergy Organization (WAO) document on allergy
nomenclature. “Intolerance” has been used to describe some non-immunological diseases. However, pediatric
gastroenterologists mix allergy and intolerance, e.g. by using the term “cow’s milk protein allergy/intolerance (CMPA/I)”,
lumping together all types of mechanisms for not tolerating cow’s milk. The basis for this mix is the fact that double-blind
oral food challenges are time-consuming and expensive. Therefore, cow’s milk exclusion and reintroduction is proposed
to be used in primary care for the diagnosis of CMPA in children with common gastrointestinal (GI) problems such as
colic and constipation. This may lead to a widespread use of hypoallergenic formulas in children without proven
CMPA. In lay language, intolerance describes “not tolerating”.
Objective: To discuss the reasons why the term “intolerance” should not be used in the area of allergy.
Results: Presently, intolerance is not part of the allergy nomenclature. It is used by lay persons to describe “not tolerating”.
Pediatricians use intolerance to describe non-immunological hypersensitivity such as lactose intolerance which is acceptable.
However, using the mixed term CMPA/I describing a variety of gastrointestinal symptoms in children, should be avoided.
The WAO Nomenclature does not clearly distinguish between non-IgE-mediated allergy and non-allergic hypersensitivity.
Conclusion: The term “intolerance” should not be used within the area of allergy. Intolerance should be better defined and
the term restricted to some non-immunological/non-allergic diseases and not mixed with allergy, e.g. by using the term
CMPA/I. A revision of the WAO nomenclature is proposed.
Keywords: Nomenclature, Immunologically mediated hypersensitivity, Allergy, Non-immunologic hypersensitivity,
Non-allergic hypersensitivity, Intolerance, IgE sensitization, Non-IgE-mediated allergy, IgE-mediated allergy,
Cell mediated allergy
Background
When asked to write the “con” paper for the Journal entitled
“Food intolerance does not exist”, I felt it was a rather simple
task. According to the World Allergy Organization (WAO)
agreement on allergen nomenclature [1], intolerance does
not exist. The nomenclature agreement is based on mecha-
nisms. Hypersensitivity is either non-immunological or im-
munological, i.e. allergy. Allergy can be either IgE-mediated
or due to other mechanisms. The WAO document does not
go into detail and leaves out subdivision of non-allergic
hypersensitivity. The nomenclature agreed upon seems
straightforward and non-controversial. The basic principle is
illustrated in Fig. 1.
Conclusion
Intolerance does not exist.
However, despite the fact that allergists do not use in-
tolerance to describe allergy or allergic diseases, the
word intolerance is used by gastroenterologists and lay
persons, which should be discussed in this context.
Cow’s milk protein allergy/intolerance, CMPA/I
In 2012 Vandenplas [2] stated: “The old term ‘intolerance’
gives rise to confusion. To avoid this, ‘intolerance’ is
proposed to be restricted to the incapacity to fully digest
carbohydrates, mainly disaccharides, of which lactose is
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the most important one.” If restricted to lactose, fructose,
sucrose etc., the term “intolerance” can be acceptable,
since it does not describe allergic or immunologic hyper-
sensitivity conditions, and implies there is no immuno-
logical, i.e. allergic, mechanism involved.
Furthermore, Vandenplas states: “A cow’s milk challenge is
the gold standard for the diagnosis of CMPA but does not
provide proof that the immune system is involved” [3, 4].
That is correct. However, for the diagnosis of an allergic con-
dition an immunological mechanism must cause the reac-
tion, either IgE-mediated or by other less well-known
mechanisms that cannot be diagnosed by any simple diag-
nostic tool.
The next step in the argumentation has been to lump
together cow’s milk protein allergy (CMPA) and cow’s
milk protein intolerance (CMPI) to CMPA/I, i.e. to mix al-
lergic and non-allergic reactions. During the “Fifth Euro-
pean pediatric motility meeting”, Vandenplas et al. [4]
wrote under “Gastrointestinal Manifestation of Cow’s Milk
Protein Allergy or Intolerance and Gastrointestinal Motil-
ity”: “The overlap between gastrointestinal manifestations
of cow’s milk protein allergy or intolerance (CMPA/I) and
frequent (functional) gastrointestinal complaints such as
gastro-esophageal reflux (disease) (GER(D)) and constipa-
tion are a topic of debate since many years. The debate is
the logic consequence of the fact that objective diagnostic
criteria for each of the entities are missing. Since not one
sign or symptom is specific for CMPA or CMPI, and since
the same is valid for GER(D) and constipation, and since
all conditions are relatively frequent, it is a given fact that
some of the allergic infants will present with reflux and/or
constipation and that some of the infants with reflux or
constipation will have CMPA/I.” This is not acceptable. Al-
lergy may not be used unless an immunologic mechanism
is proven or highly probable. In cases where there is no
immunological mechanism, the term “allergy” may not be
used. The goal must be to differ, as far as possible, between
immunological, i.e. allergic and non-immunological
mechanisms.
Vandenplas et al. continue: “If the reintroduction of CMP
causes relapse of symptoms, the diagnosis seems established,
since a challenge-test is considered as the golden standard
diagnostic test. Although false positive diagnostic testing
(specific IgE, skin prick test, patch test) does occur, the
diagnosis of CMPA is ‘likely’ if patients present with sug-
gestive symptoms and (one of) these tests show positive
results. But, sensitization with CMP can also lead to non-
IgE dependent reactions. Some symptoms are more fre-
quently linked to non-IgE mediated allergy”. . . . “In daily
routine, there is no diagnostic testing for non-IgE-mediated
allergic reactions”. This statement allows for the possibility of
unrestricted use of CM avoidance, i.e. use of hypoallergenic
formulas, in infants with common non-specific complaints.
This is not evidence based.
The conclusions by Vandenplas seem to be: Oral prov-
ocations are difficult to perform in general practice and
do not indicate mechanism, i.e. IgE-mediated allergy,
non-IgE-mediated allergy or non-allergic hypersensi-
tivity. Therefore, these diagnoses are lumped together
under CMPA/I.
Allergen specific IgE tests indicate sensitization not allergic
disease. To prove CMPA, a history of immediate reaction to
CMP should be supported by an oral provocation, unless
clear severe allergic symptoms appeared in close connection
with food intake. Then, with a suggestive clinical history,
atopic sensitization, and a supervised oral provocation test,
the infant has been proven to have an atopic/IgE mediated
CMPA. With any of the common symptoms, but without
IgE sensitization, the infant does not have IgE-mediated
allergy to CMP. Then two possibilities remain; non-IgE-
mediated allergic CMPA and non-allergic CMP hypersen-
sitivity. To differentiate between these conditions is often
not easy. There are no simple diagnostic methods diag-
nosing non-IgE-mediated allergy. According to Vanden-
plas et al. [4] symptoms common in infants (Table 1) may
indicate CMPA/I. Since performing oral challenges is
claimed to be difficult, Vandenplas introduced a scoring
system [5], Table 2, as a basis for an algorithm [6] to be
used in general practice or by practicing pediatricians
based on the degree of common gastrointestinal symp-
toms, atopic eczema and some respiratory symptoms.
The problems are
 Symptoms in the scoring system [5], possibly
indicating CMPA/CMPI, include symptoms exhibited
by the majority of infants. In the majority of cases,
these symptoms are not based on an immunologic
mechanism, Table 1 [4]. However, since proper
Double Blind Placebo Controlled Food Challenge
(DBPCFC) in infants with colic or constipation have
not been published so far, the scientific proof for the

















Fig. 1 The principle of the EAACI/WAO nomenclature. (Original work
of the author)
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 Non-IgE-mediated allergy and non-allergic
hypersensitivity are lumped together.
 Reintroduction [4] of cow’s milk at home without
supervision and retrospective evaluation by a general
practitioner or general pediatrician is considered
equal to oral provocation supervised by a specialized
team, naming it oral provocation, the gold standard.
According to the argumentation by Vandenplas et al.,
any gastro-intestinal symptom may be caused by non-IgE-
mediated CMPA/“intolerance” (CMPA/I), e.g. colic and
constipation, Table 1. This type of argumentation is the
impetus for the widespread use of non-specific criteria for
the diagnosis of “CMPA/I” in primary care. In a web-based
survey among practicing pediatricians in Europe [7], “the
prevalence of infants presenting with CMA was 47 % as
perceived by general pediatricians. Eczema, vomiting, diar-
rhea, rashes/hives, blood in stools and a symptom duration
of more than 1 week were features associated with CMA.
Only 21 % of the doctors performed diagnostic allergy
tests including cow’s milk-specific serum IgE or skin prick
test. Sixty seven percent of the responding general pedia-
tricians indicated clinical signs alone or an empirical trial
of a replacement formula were sufficient for diagnosis”
[7]. A hypoallergenic CM formula was the most
commonly used elimination diet. However, 20 % of prac-
ticing pediatricians used amino acid based formulas in
these children. This non-evidence-based clinical decision
may generate anxiety among parents, unnecessary elimin-
ation diets, disabling diagnoses, and un-necessary ex-
penses to parents and even the society, in some countries.
Fortunately, the European Society of Pediatric Gastroenter-
ology Hepatology and Nutrition (ESPGHAN) position paper
Table 2 Symptom-based score according to Vandenplas et al. [5]
Symptom Score







Regurgitation 0–6 0: 0–2 episodes/day
1: ≥3 to ≤5 of small volume
2: >5 episodes of >1 coffee spoon
3: >5 episodes of ± half of the feedings
in < half of the feedings
4: continuous regurgitations of
small volumes > 30 min after each
feeding
5: regurgitation of half to complete
volume of a feeding in at least half
of the feedings
6: regurgitation of the complete
volume after each feeding
Stools (according
to Bristol scale)
0–6 4: type 1 and 2 (hard stools)a
0: type 3 and 4 (normal stools)
2: type 5 (soft stool)
4: type 6 (liquid stool, if unrelated
to infection)









0–6 Urticaria (no: 0/yes: 6)




aCompare constipation in Table 2, my remark
(Permission received from John Wiley & Sons, Ltd.)








Blood in stool without failure to thrive
Dermatological
Atopic dermatitis
Swelling of lips or eye lids
Urticaria unrelated to acute infections,





Broncho-constriction unrelated to infection
General
Persistent distress
Colic (≥3 h/day wailing/irritable) over a
period of >3 weeks
Infants with CMPA in general show one or more of the listed symptoms
CMPA cow’s milk protein allergy
aCompare type of stool in Table 2, my remark
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[8] on the management of CMPA does not use the confusing
term CMPA/I.
The present nomenclature
When preparing this article, I read the nomenclature papers
by EAACI [9] and WAO [1] once again, concentrating on
gastrointestinal problems, which is most often part of the
“intolerance” discussion. I did not find any “intolerance” in
these documents.
However, in the EAACI position paper [9], it is proposed
that “an adverse reaction to food should be called food hyper-
sensitivity …. When immunologic mechanisms have been
demonstrated, the appropriate term is food allergy, and, if
the role of IgE is highlighted, the term is IgE-mediated food
allergy”. So far, correct. However, the authors continue, “All
other reactions, previously sometimes referred to as ‘food
intolerance’, should be referred to as non-allergic food
hypersensitivity”. Thus, the group of non-IgE-mediated
mechanisms is not mentioned in that text or as being part
of food intolerance.
In the WAO document [1], the definitions are clear in the
general introduction (Fig. 2). However, under “Food allergy”
it is stated: “The appropriate term is food allergy when im-
munologic mechanisms have been demonstrated.… If IgE is
involved in the reaction, the term IgE-mediated food allergy
is appropriate. All other reactions should be referred to as
non-allergic food hypersensitivity”. There is a gap in not
mentioning non-IgE-mediated allergic mechanisms.
The matter of these two exclusions probably confuses
some readers and opens up the possibility for using
different symptoms to diagnose CMPA that includes
non-IgE-mediated CMPA, and to add “I”, i.e. using the
term CMPA/I. The wording of the WAO nomenclature
position paper should be changed to indicate that food
allergy caused by non-IgE-mediated mechanisms exists.
Future use of intolerance
“Intolerance to” is often used by lay persons to describe
“not tolerating” or “getting symptoms from contact with”
without bothering with the mechanism causing the
“intolerance”, thus rather similar to the EAACI/WAO
term “hypersensitivity”. Since intolerance is an accepted
term, but not indicating allergy, maybe intolerance could
be used as a substitute for non-allergic/non-immunological
diseases, which is an awkward. Intolerance could be intro-
duced as a shorter term for non-immunological hypersensi-
tivity similar to using allergy instead of immunologically
mediated hyperreactivity. This would also have a positive
effect: in the future intolerance will be opposite to allergy,
i.e. it will indicate absence of any type of allergy, or
immunological mechanism.
In addition, I believe it would be of value to discuss
defining different non-IgE-mediated and non-allergic
(intolerant?) diseases in a future nomenclature position
paper by WAO. Finally, since all mechanisms involved
are not fully understood, an easily understood common
name for non-IgE-mediated allergy/non-IgE-mediated
immunological hypersensitivity should be introduced.
In the WAO position paper, non-atopic eczema is men-
tioned, but non-atopic is not used for food allergies. Thus,
non-IgE-mediated hypersensitivity/allergy is proposed be
named, “non-atopic food allergy”, which is the opposite of
IgE-mediated food hypersensitivity or atopic food allergy.
Alimentary Tract Hypersensitivity
Non-Allergic Food HypersensitivityFood Allergy
Other types of Alimentary 
Tract Hypersensitivity
Food Hypersensitivity
Non-IgE-mediated Food AllergyIgE-mediated Food Allergy
Fig. 2 The principle of the EAACI/WAO nomenclature adopted to





Subdivided based on 
causative agent(s),
e.g. Lactose intolerance, 
Aspirin intolerance 
etc.Subdivided based on 
mechanisms, i.e. Type II a 











Fig. 3 Illustration of proposed minor changes of the food hypersensitivity nomenclature, using “intolerance” as short for “non-allergic hypersensitivity”/
“non-immunological hypersensitivity”. (Original work of the author)
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Dividing “non-IgE-mediated food allergy” based on the
revised Gell and Coombs nomenclature [10], as pro-
posed by Uzzaman and Cho, should be discussed [11].
The proposed basic principle is shown in Fig. 3, in-
cluding a proposal for sub-division of “non-IgE-mediated
allergy” adding the present sub-groups of Type II and IV
allergy.
Intolerance in media
The use of “intolerance” in lay media is often confusing.
As an example, I refer to Wikipedia, Medical/biological
intolerance (Table 3) [12]. The introduction, “Intolerance,
or hypersensitivity, includes but is not limited to allergy” is
highly confusing. This introduction and several of the
intolerances mentioned are certainly not acceptable
(Table 4).
Furthermore, Wiktionary informs the following: “Intoler-
ance: sensitivity to a food or drug; allergy. (medicine): food
intolerance: the state of being intolerant; extreme sen-
sitivity to a food or drug; allergy” [13].
Future nomenclature
I would propose that non-IgE-mediated allergy be sub-
divided according to Gel and Coombs; and allergic
diseases, and diseases or symptoms with an obvious
immunological background, but not yet with a fully
understood mechanism [14], are mentioned under this
heading. Furthermore, the often-used word “tolerance”
with different contextual meanings, should be better
defined unanimously, and sensitization vs. clinical
allergy should be better defined.
To influence the use of “intolerance”, it is essential
that the WAO extends its nomenclature document with
a more detailed description of non-immunological dis-
eases (intolerance?), by collaborating with competent
adult and pediatric sister societies. Then, it is essential
that the nomenclature be spread to relevant journals,
societies and lay organizations.
Conclusions
 Intolerance does not exist within the area of allergy
and should not be part of the allergy/immunological
hypersensitivity nomenclature.
 The mixed term “cow’s milk protein allergy/
intolerance” (CMPA/I) should be actively
counteracted in collaboration with related societies.
 Intolerance is proposed to indicate gastrointestinal
lack of enzyme-causing GI symptoms (lactose,
fructose, sucrose intolerance).
 Intolerance or any other easily recognized term
should be added to non-allergic/ non-immunologic
hypersensitivity which is too awkward to be
generally accepted. This action will clearly separate
non-IgE-mediated hypersensitivity/allergy from
non-immunologic hypersensitivity (/intolerance).
 Non-IgE-mediated hypersensitivity/allergy should be
given a shortened name.
Other terms often used in discussions on allergy, such
as “tolerance”, “sensitization” vs. “clinical allergy” and
“de-sensitization”, should be better defined.
Table 3 Medical/biological intolerance according to
Wikipedia [12]a






• Hereditary fructose intolerance
• Lactose intolerance
• Lysinuric protein intolerance
• Multiple chemical sensitivity
• Orthostatic intolerance (?)
• Perfume intolerance
• Salicylate intolerance, also




• Milk soy protein intolerance
aDownloaded on June 1 2015
Table 4 The types of allergic mechanisms as described by Gell and Coombs [10], revision as proposed by Uzzaman and Cho [11]
No Type Mechanism Disease
I Immediate type allergy IgE Anaphylaxis Atopic asthma, rhino-conjunctivitis
immediate type urticaria etc.
II a Cytotoxic or IgG/IgM mediated IgG/IgM Auto-immune diseases
II b Antibody-mediated cell stimulating Antibodies cell stimulation Diffuse goitre Basedow’s/Grave’s disease
“Autoimmune” chronic idiopathic urticaria
III Immune complex mediated - IgG/IgM - complement Lupus erythematosus Epidermolysis bullosa
IV a Macrophage activation CD4(+)Th1 lymphocyte mediated with
activation of macrophages
Granulomatous diseases Type I diabetes
mellitus
IV b CD4(+)Th2 eosinophilic reaction CD4(+)Th2 lymphocytes and eosinophils Chronic asthma and chronic rhinitis
IV c Cytotoxic CD8(+) T lymphocyte incused
apoptosis
Cytotoxic CD8(+) T lymphocytes
Perforin-granzme B apoptosis
Stevens-Johnson syndrome Toxic epidermal
necrolysis
IV d T-lymphocyte-driven neutrophilic
inflammation
T-lymphocytes Neutrophilic inflammation Pustular psoriasis Acute generalized
exanthematous pustulosis
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